CTLT
Catalent Inc.

1,372
Loading...
Loading...
News
all
press releases
Catalent Announces New Board Appointments
Catalent, Inc., the leader in enabling the development and supply of better treatments for patients worldwide, today announced that it has appointed Susan Mahony, Marie-France Tschudin and Tim...
Business Wire·7mo ago
News Placeholder
More News
News Placeholder
Lennox International Set to Join SandP 500 and BILL Holdings to Join SandP MidCap 400
Lennox International Set to Join S&P 500 and BILL Holdings to Join S&P MidCap 400 Lennox International Set to Join S&P 500 and BILL Holdings to Join S&P MidCap 400 PR Newswire NEW YORK, Dec. 18, 2024...
PR Newswire·9mo ago
News Placeholder
Novo Holdings Completes Acquisition of Catalent
Catalent, Inc. (Catalent), a leader in enabling the development and supply of better treatments for patients worldwide, and Novo Holdings A/S (Novo Holdings), a global life sciences investment firm...
Business Wire·9mo ago
News Placeholder
US Futures Jump, Ignore Global Selloff While Focusing On Imminent Rate Cut
US Futures Jump, Ignore Global Selloff While Focusing On Imminent Rate Cut The last full week of 2024 started off with a burst of US exceptionalism which helped US equity futures shrug...
Zero Hedge·9mo ago
News Placeholder
Catalent and Novo Holdings Fulfill All Regulatory Closing Conditions for Pending Transaction
Catalent, Inc. (Catalent, NYSE: CTLT), a leader in enabling the development and supply of better treatments for patients worldwide, and Novo Holdings A/S (Novo Holdings), a global life sciences...
Business Wire·9mo ago
News Placeholder
QuidelOrtho Announces Appointment of Two Independent Directors to its Board
QuidelOrtho Corporation (Nasdaq: QDEL) (the Company or QuidelOrtho), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and...
Business Wire·9mo ago
News Placeholder
Catalent and Novo Holdings Receive European Commission Unconditional Approval for Pending Transaction
Catalent, Inc. (Catalent, NYSE: CTLT), a leader in enabling the development and supply of better treatments for patients worldwide, and Novo Holdings A/S (Novo Holdings), a global life sciences...
Business Wire·9mo ago
News Placeholder
Catalent, Inc. Reports First Quarter Fiscal 2025 Results
Catalent, Inc. (NYSE: CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, today announced financial results for the first quarter of fiscal 2025...
Business Wire·10mo ago
News Placeholder
Super Micro shares tumble following disturbing news
Analysts at Needham had seen enough.The investment firm said on Oct. 30 that it was suspending its buy rating of Super Micro Computer (SMCI) shares after the maker of liquid-cooled...
TheStreet.com - Tech·11mo ago
News Placeholder
Roche's Q3 Sales Surge Led By Ocrevus, Vabysmo, Urges Regulators To Block Novo Holdings' $16.5B Catalent Acquisition
Roche reported a 9% increase in third-quarter sales, driven by strong performance from Ocrevus and Vabysmo. Roche also raised concerns over the Catalent acquisition. read more...
Benzinga·11mo ago

Latest CTLT News

View

Advertisement. Remove ads.

Advertisement. Remove ads.